We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.82%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$231B
AUM Growth
-$701M
Cap. Flow
-$4.96B
Cap. Flow %
-2.15%
Top 10 Hldgs %
13.13%
Holding
8,738
New
866
Increased
3,703
Reduced
3,052
Closed
702

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$514M
2
MDLZ icon
Mondelez International
MDLZ
+$421M
3
COR icon
Cencora
COR
+$225M
4
IVZ icon
Invesco
IVZ
+$212M
5
MON
Monsanto Co
MON
+$205M

Sector Composition

Rank Sector Weight
1 Technology 8.74%
2 Financials 7.28%
3 Healthcare 6.05%
4 Consumer Discretionary 5.36%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIEG
6276
DELISTED
FI Enhanced Global High Yield Exchange Traded Notes
FIEG
$34K ﹤0.01%
261
EMI
6277
DELISTED
Eaton Vance Michigan Municipal Income Trust
EMI
$34K ﹤0.01%
2,676
-1,393
-34% -$17.5K
BSX icon
6278
PUT
Boston Scientific
BSX
$71.4B
$33K ﹤0.01%
1,000
-9,500
-90% -$287K
BY icon
6279
Byline Bancorp
BY
$1.79B
$33K ﹤0.01%
1,460
+623
+74% +$13.9K
CLDX icon
6280
Celldex Therapeutics
CLDX
$3.26B
$33K ﹤0.01%
4,394
+2,072
+89% +$27.7K
CNTY icon
6281
Century Casinos
CNTY
$33.5M
$33K ﹤0.01%
3,798
+993
+35% +$8.23K
EPI icon
6282
CALL
WisdomTree India Earnings Fund ETF
EPI
$2.05B
$33K ﹤0.01%
+1,300
New +$33.8K
GNTY
6283
DELISTED
Guaranty Bancshares
GNTY
$33K ﹤0.01%
1,098
+229
+26% +$6.92K
IDHQ icon
6284
Invesco S&P International Developed Quality ETF
IDHQ
$958M
$33K ﹤0.01%
+1,377
New +$33.1K
LYTS icon
6285
LSI Industries
LYTS
$913M
$33K ﹤0.01%
6,243
-4,538
-42% -$27.6K
MRSN
6286
DELISTED
Mersana Therapeutics
MRSN
$33K ﹤0.01%
74
+9
+14% +$3.95K
ORN icon
6287
Orion Group Holdings
ORN
$410M
$33K ﹤0.01%
3,999
+1,916
+92% +$14K
RFEM icon
6288
First Trust RiverFront Dynamic Emerging Markets ETF
RFEM
$81.4M
$33K ﹤0.01%
491
+462
+1,593% +$33.2K
SILC icon
6289
Silicom
SILC
$239M
$33K ﹤0.01%
847
+460
+119% +$17.6K
TFSL icon
6290
TFS Financial
TFSL
$5.01B
$33K ﹤0.01%
2,069
-1,179
-36% -$18.2K
TRNO icon
6291
Terreno Realty
TRNO
$7.2B
$33K ﹤0.01%
880
-473
-35% -$17.4K
PVLA
6292
Palvella Therapeutics
PVLA
$2.23B
$33K ﹤0.01%
+81
New +$38.5K
EVBN
6293
DELISTED
Evans Bancorp Inc
EVBN
$33K ﹤0.01%
+697
New +$32.2K
ITI
6294
DELISTED
Iteris, Inc.
ITI
$33K ﹤0.01%
6,843
+6,543
+2,181% +$32.7K
AVID
6295
DELISTED
Avid Technology Inc
AVID
$33K ﹤0.01%
6,334
+44
+0.7% +$215
JAX
6296
DELISTED
J. Alexander's Holdings, Inc.
JAX
$33K ﹤0.01%
2,915
+1,922
+194% +$22.9K
UCI
6297
DELISTED
E-TRACS UBS Bloomberg CMCI ETN
UCI
$33K ﹤0.01%
2,129
-853
-29% -$13.5K
PGNX
6298
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$33K ﹤0.01%
4,049
-113,995
-97% -$870K
GASX
6299
DELISTED
Direxion Daily Natural Gas Bear 3X Shares
GASX
$33K ﹤0.01%
18,950
-7,720
-29% -$16.4K
GASL
6300
DELISTED
Direxion Daily Natural Gas Related Bull 3X Shares
GASL
$33K ﹤0.01%
+3
New +$32.2K

Similar funds

UBS Group's Q2 2018 Portfolio in Review

As of Q2 2018, UBS Group held 8,738 positions worth $231B, down 0.3% from $232B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2018 filing shows 866 new, 3,703 increased, 3,052 reduced and 702 closed positions. Its largest new stake was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M. The largest sale was NXP Semiconductors, an estimated $514M.

By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 8.1% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2018 buy was Invesco Ultra Short Duration ETF: 519,362 shares worth $26.1M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $1.01B increase.
  • UBS Group's biggest Q2 2018 reduction was NXP Semiconductors, cutting an estimated $514M.
  • UBS Group fully exited Monsanto Co in Q2 2018, selling an estimated $205M.
  • UBS Group's ten largest holdings make up 13% of its $231B portfolio in Q2 2018.
  • UBS Group opened 866 new positions and closed 702 in Q2 2018.
  • UBS Group's portfolio value fell 0.3% quarter-over-quarter to $231B.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.